Therefore, in this study, we tested this hypothesis in preclinical models of PDA and subsequently demonstrated a significant effect of TGF-β blocking antibodies on Tregs in a vaccine dependent manner. This evidence concerns the gene TGFB1 and Patent ductus arteriosus.